The Correlation between Serum Levels of Cytokeratin Tumor Markers does Reflect Their Molecular Characterization

Sundstroem B. , Stigbrand T. Cytokeratins and tissue polypeptide antigen. Int J Biol Markers (in press).

Mellerik D.M. , Osborn M. , Weber K. On the nature of serological tissue polypeptide antigen (TPA); monoclonal keratin 8, 18, 19 antibodies react differently with TPA prepared from human cultured carcinoma cells and TPA in human serum. Oncogene 1990; 5: 100–17.

Bjorklund B. , Bjorklund V. , Wiklund B. A human tissue polypeptide related to cancer and placenta: I. Preparation and properties; II Assay technique; III Clinical studies of 1483 individuals with cancers and other conditions. In: Immunological techniques for detection of cancer. The Folksam Symposium. Stockholm: Bonimers, 1973; 133–87.

Bjorklund B. On the nature and clinical use of tissue polypeptide antigen (TPA). Tumor Diagnostik 1980; 1: 9–20.

Montinari F. , Luporini G. The tissue polypeptide antigen. In: Ballestra A.M. , Torre G.C. , Bombardieri E. , Gion M. , Molina R. , eds. Updating on tumor markers in tissues and in biological fluids. Torino: Minerva Medica 1993; 639–50.

Bjorklund B. Tumor markers TPA, TPA-S and cytokeratins. A working hypothesis. Tumordiagn u Ther 1992; 13: 78–80.

Bodenmuller H. , Doniè F. , Kaufmann M. , Banauch D. The tumor markers TPA, TPS, TPACyk, and Cyfra 21–1 react differently with the keratins 8, 18 and 19. Int J Biol Markers (in press).